Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

546 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom.
Moore JL, Green M, Santaolalla A, Deere H, Evans RPT, Elshafie M, Lavery A, McManus DT, McGuigan A, Douglas R, Horne J, Walker R, Mir H, Terlizzo M, Kamarajah SK, Van Hemelrijck M, Maisey N, Sita-Lumsden A, Ngan S, Kelly M, Baker CR, Kumar S, Lagergren J, Allum WH, Gossage JA, Griffiths EA, Grabsch HI, Turkington RC, Underwood TJ, Smyth EC, Fitzgerald RC, Cunningham D, Davies AR; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) study group, The Guy's and St Thomas' Oesophago-gastric Research Group, and The PROGRESS study group. Moore JL, et al. J Clin Oncol. 2023 Oct 1;41(28):4522-4534. doi: 10.1200/JCO.23.00139. Epub 2023 Jul 27. J Clin Oncol. 2023. PMID: 37499209
Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma - A comparison of the FLOT and 'MAGIC' regimens.
Moore JL, Kumar S, Santaolalla A, Patel PH, Kapiris M, Van Hemelrijck M, Maisey N, Hill M, Lagergren J, Gossage JA, Kelly M, Chaudry A, Allum WH, Baker CR, Cunningham D, Davies AR; Guy's and St Thomas' Oesophago-gastric Research Group including the following co-authors. Moore JL, et al. Eur J Cancer. 2022 Mar;163:180-188. doi: 10.1016/j.ejca.2021.12.021. Epub 2022 Jan 31. Eur J Cancer. 2022. PMID: 35085931
[No title available]
[No authors listed] [No authors listed] PMID: 35098364
Patient perspectives on key symptoms and preferences for follow-up after upper gastro-intestinal cancer surgery.
Pucher PH, Coombes A, Evans O, Taylor J, Moore JL, White A, Lagergren J, Baker C, Kelly M, Gossage JA, Dunn J, Zeki S, Byrne BE, Andreyev J, Davies AR; RESTORE study group, Guy’s, St Thomas’ Oesophago-gastric research group. Pucher PH, et al. Among authors: moore jl. Support Care Cancer. 2022 Jun;30(6):5269-5275. doi: 10.1007/s00520-022-06922-w. Epub 2022 Mar 11. Support Care Cancer. 2022. PMID: 35275293 Free PMC article.
Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma.
Moore JL, Subesinghe M, Santaolalla A, Green M, Deere H, Van Hemelrijck M, Lagergren J, Chicklore S, Maisey N, Gossage JA, Kelly M, Baker CR, Davies AR; Guy’s and St Thomas’ Oesophago-gastric Research Group. Moore JL, et al. Eur Radiol. 2023 May;33(5):3647-3659. doi: 10.1007/s00330-023-09482-7. Epub 2023 Mar 15. Eur Radiol. 2023. PMID: 36920518 Free PMC article.
Delayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer: (DICE) Study.
Chidambaram S, Owen R, Sgromo B, Chmura M, Kisiel A, Evans R, Griffiths EA, Castoro C, Gronnier C, MaoAwyes MA, Gutschow CA, Piessen G, Degisors S, Alvieri R, Feldman H, Capovilla G, Grimminger PP, Han S, Low DE, Moore J, Gossage J, Voeten D, Gisbertz SS, Ruurda J, van Hillegersberg R, D'Journo XB, Chmelo J, Phillips AW, Rosati R, Hanna GB, Maynard N, Hofstetter W, Ferri L, Berge Henegouwen MI, Markar SR. Chidambaram S, et al. Ann Surg. 2023 Nov 1;278(5):701-708. doi: 10.1097/SLA.0000000000006028. Epub 2023 Jul 21. Ann Surg. 2023. PMID: 37477039
Prehabilitation exercise before oesophagectomy: long-term follow-up of patients declining/withdrawing from the program.
Knight W, Moore JL, Whyte GP, Zylstra J, Lane AM, Pate J, Gervais-Andre L, Maisey N, Hill M, Tham G, Lagergren J, Kelly M, Baker C, Van Hemelrijck M, Goh V, Gossage J, Browning M, Davies AR. Knight W, et al. Among authors: moore jl. Br J Surg. 2023 Nov 9;110(12):1668-1672. doi: 10.1093/bjs/znad250. Br J Surg. 2023. PMID: 37611139 No abstract available.
Reply to R. Sun et al.
Moore JL, Santaolalla A, Van Hemelrijck M, North B, Davies AR. Moore JL, et al. J Clin Oncol. 2024 Jan 20;42(3):367-368. doi: 10.1200/JCO.23.02131. Epub 2023 Nov 21. J Clin Oncol. 2024. PMID: 37988643 No abstract available.
The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3).
Girardi F, Rous B, Stiller CA, Gatta G, Fersht N, Storm HH, Rodrigues JR, Herrmann C, Marcos-Gragera R, Peris-Bonet R, Valkov M, Weir HK, Woods RR, You H, Cueva PA, De P, Di Carlo V, Johannesen TB, Lima CA, Lynch CF, Coleman MP, Allemani C; CONCORD Working Group. Girardi F, et al. Neuro Oncol. 2021 Oct 1;23(10):1765-1776. doi: 10.1093/neuonc/noab067. Neuro Oncol. 2021. PMID: 33738488 Free PMC article.
546 results